ArriVent BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVBP and other ETFs, options, and stocks.About AVBP
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
CEOZheng Bin Yao
CEOZheng Bin Yao
Employees52
Employees52
HeadquartersNewtown Square, Pennsylvania
HeadquartersNewtown Square, Pennsylvania
Founded2021
Founded2021
Employees52
Employees52
AVBP Key Statistics
Market cap904.89M
Market cap904.89M
Price-Earnings ratio-5.19
Price-Earnings ratio-5.19
Dividend yield—
Dividend yield—
Average volume442.13K
Average volume442.13K
High today$22.48
High today$22.48
Low today$21.81
Low today$21.81
Open price$22.33
Open price$22.33
Volume208.54K
Volume208.54K
52 Week high$29.71
52 Week high$29.71
52 Week low$15.47
52 Week low$15.47
Stock Snapshot
The current ArriVent BioPharma(AVBP) stock price is $21.97, with a market capitalization of 904.89M. The stock trades at a price-to-earnings (P/E) ratio of -5.19.
On 2025-12-27, ArriVent BioPharma(AVBP) stock traded between a low of $21.81 and a high of $22.48. Shares are currently priced at $21.97, which is +0.7% above the low and -2.3% below the high.
The ArriVent BioPharma(AVBP)'s current trading volume is 208.54K, compared to an average daily volume of 442.13K.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $29.71 and a 52-week low of $15.47.
In the last year, ArriVent BioPharma(AVBP) shares hit a 52-week high of $29.71 and a 52-week low of $15.47.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AVBP. This list is generated using Robinhood data, and it’s not a recommendation.